PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 114 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 45.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $258,000 | +2.8% | 100,400 | 0.0% | 0.00% | – |
| Q4 2020 | $251,000 | +20.7% | 100,400 | 0.0% | 0.00% | – |
| Q3 2020 | $208,000 | -33.1% | 100,400 | 0.0% | 0.00% | – |
| Q2 2020 | $311,000 | +314.7% | 100,400 | +203.3% | 0.00% | – |
| Q1 2020 | $75,000 | -37.5% | 33,100 | 0.0% | 0.00% | – |
| Q4 2019 | $120,000 | -33.0% | 33,100 | -6.2% | 0.00% | – |
| Q2 2018 | $179,000 | – | 35,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
| BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
| Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
| Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
| EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
| Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
| Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
| XTX Topco Ltd | 32,650 | $169,000 | 0.06% |